Bioxytran (BIXT) Net Equity Issued and Repurchased (2010 - 2026)
Bioxytran (BIXT) posted Net Equity Issued and Repurchased of $145701.0 for Q1 2026, up 482.8% sequentially from $25000.0 in Q2 2016.
Bioxytran (BIXT) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Bioxytran has reported Net Equity Issued and Repurchased for 5 years, with the latest figure at $145701.0 in Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $145701.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145701.0 (changed N/A YoY) and the FY2025 annual result came in at $438986.0, up 596.8% from the prior year.
- Net Equity Issued and Repurchased rose to $145701.0 in Q1 2026 per BIXT's latest filing, from $25000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $145701.0 in Q1 2026 and troughed at $145701.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - | 45,346.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145,701.00 |
| Mar 31, 2026 | 145,701.00 |
| Jun 30, 2016 | 25,000.00 |
| Jun 30, 2016 | 25,000.00 |
| Mar 31, 2016 | 25,000.00 |
| Mar 31, 2016 | 25,000.00 |
| Sep 30, 2012 | 5,250.00 |
| Sep 30, 2012 | 5,250.00 |
| Jun 30, 2012 | 2,000.00 |
| Jun 30, 2012 | 2,000.00 |
| Mar 31, 2012 | 10,000.00 |
| Mar 31, 2012 | 10,000.00 |
| Dec 31, 2011 | 145,300.00 |
| Dec 31, 2011 | 145,300.00 |
| Sep 30, 2011 | -26,939.00 |
| Sep 30, 2011 | -26,939.00 |
| Jun 30, 2011 | 291,641.00 |
| Jun 30, 2011 | 291,641.00 |
| Mar 31, 2011 | 138,745.00 |
| Mar 31, 2011 | 138,745.00 |